GPX-150 for Injection

DRUG2 trials

Sponsors

Gem Pharmaceuticals

Conditions

Advanced Solid Tumors - Phase 1 PopulationSoft Tissue Sarcoma

Phase 1

Safety Study of GPX-150 in Patients With Solid Tumors

CompletedNCT00710125

Gem PharmaceuticalsAdvanced Solid Tumors - Phase 1 Population

Start: 2008-01-31End: 2013-10-31Updated: 2014-08-05

Phase 2

Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

CompletedNCT02267083

Gem PharmaceuticalsSoft Tissue Sarcoma

Start: 2015-01-07End: 2016-08-18Updated: 2018-01-10

Related Papers

A phase 2 trial of 5-imino-13-deoxydoxorubicin (GPX-150) in metastatic and non-resectable soft tissue sarcomas.

Journal of Clinical Oncology2016-05-201 citations